Alveolar carcinoma of the lung has always been surrounded by controversy. Morphological criteria for its diagnosis are ill defined, its distinction from adenocarcinoma is often arbitary, ' and it is encumbered by a multiplicity of synonyms, reflecting its uncertain histogenesis. 23 Its very existence has been questioned,4 5 though most authorities accept it as an entity6-12-and yet tumours of this type are not rare, comprising up to 9% of all pulmonary cancers. '3 The first case was reported over a century ago '4 and currently there are more than 1000 in published reports. '3 During the last decade or so some new facts have emerged about the nature, aetiology, and natural history of alveolar carcinoma. In particular, it now appears that this is a heterogeneous group of tumours which appear similar on gross examination and by light microscopy but which differ at the ultrastructural level'5 -a concept leading to difficulties in communication between histopathologists and clinicians. This paper therefore falls into two broad sections. In the review of clinical and radiological features, gross pathology, and light microscopy alveolar carcinoma is treated for practical purposes as a single entity; while histogenesis and aetiology are discussed in the light of more recent developments.
Definition and nomenclature
The accepted diagnostic criteria of alveolar carcinoma on the basis of gross examination and light microscopy are: (1) absence of a primary adenocarcinoma elsewhere; (2) absence of a demonstrable central bronchogenic origin; (3) a peripheral location in the lung parenchyma; (4) intact interstitial framework of the lung; (5) a histological appearance setting it apart from other lung tumours and characterised by the growth of malignant cells along alveolar walls.' 2 4 6 9 Over the years many descriptive terms have been used for this tumour, including pulmonary adenomatosis, bronchiolar carcinoma, alveolar cell carcinoma and many others.3 The currently preferred name is bronchioloalveolar carcinoma, which was coined in 1960 by Liebow,2 the implication being that the cell of origin was uncertain. For the purposes of this article I use the term alveolar carcinoma, emphasising that it refers to the histological pattern and has no histogenetic connotation. "Bronchioloalveolar carcinoma" is clumsy to write and difficult to say aloud.
Historical background
The first published account of alveolar carcinoma is attributed to Malassez,'4 who in 1876 described in detail a multinodular tumour in a woman aged 47, and more briefly a localised tumour in a man of 50 years, "chez lequel on ne trouvait aucune trace de syphilis anterieure." Reports of a pneumonic variant,'6 1 multinodular tumours confined to the chest, '8 and a further example of the localised type '9 appeared during the years 1903-9. Skorpil20 carried out the first lobectomy for alveolar carcinoma in 1936 and the patient survived for five years despite secondary deposits in hilar lymph nodes.
In 1949 Swan2' was able to find only 52 published cases, but in the ensuing two decades many more were published.522 32 The question of histogenesis, however, remained unresolved2; some authors believed that the origin of the tumour was multicentric,223334 whereas other favoured a unicentric origin with spread via bronchi and lymphatics. 23 Another school of thought doubted the place of alveolar carcinoma as a primary lesion of the lung; it was pointed out that secondary carcinomas sometimes mimic its appearance exactly.35 Nevertheless, alveolar carcinoma was generally accepted as an entity and it was noted that surgical treatment of the solitary form was associated with an excellent pro- 23 28 gnosis.
In parallel with these developments, similar tumours were being reported in animals.2 Of particular interest was jaagsiekte, a contagious pulmonary disease of sheep, which is characterised by proliferation of alveolar lining cells in its early stages and later by the development of a malignant lesion 166 Alveolar carcinoma: a review 36 identical to human alveolar carcinoma. This condition was studied initially in South Africa, but subsequently cases appeared in Peru, Iceland, and the United States. Its aetiology is clearly viral, but its relationship to human disease remains uncertain.
Clinical features
Alveolar carcinoma accounts for about 5% of all lung cancers, but the actual figure quoted varies from 1-1 % to 9-0%37 in published reports. An incidence as low as 0-4% was cited in an early paper, 23 probably because of difficulties in distinguishing this tumour from adenocarcinoma. Although some workers have noted a female preponderance,' 28 31 38 the overall sex incidence among published cases is 58-5% in men and 41-3% in women. '3 Solitary resectable lesions appear to be more common in women, '3 and it is noteworthy that alveolar carcinoma is more equally distributed between the sexes than other forms of lung cancer. ' 58 Radiological appearances in such cases may be misleading: an apparent single nodule may be accompanied by others which are only found at thoractomy.' Preoperative computed tomography has proved of value in detecting small lesions of this nature.59 60 Later in the course of the disease multiple radiologically apparent nodules appear, often in both lung fields-an appearance which implies widespread dissemination and is associated with a poor prognosis.'0 Cavitation and calcification are rare; but there may be a central lucent area, presumably due to the presence of unaffected airways.7 Occasionally alveolar carcinoma presents with multiple cavitating lesions. 6' 62 The lobar pneumonic type of change is a relatively late manifestation, although in some earlier series it accounts for over 30% of the total.7 The infiltrate need not extend to include a whole segment or lobe and may have a soft, ill defined edge.55 One of the characteristic features of this type of lesion is the presence of an "air bronchogram" on tomography and a "leafless tree" appearance on bronchography.' 6 7 Because alveolar carcinoma is a peripheral lesion, atelectasis and obstructive change due to large airway obstruction is rare. Pneumothorax has been described, and there may be a massive pericardial effusion.6364
Any opacity which does not resolve or progresses and is associated with pre-existing lung disease should therefore be regarded with suspicion. Cer 
Gross pathology
In necropsy or surgical material alveolar carcinoma manifests itself as either an isolated nodule, as multiple and often widely disseminated nodules, or as diffuse "pneumonic" consolidation.2574124456 Edgerton and colleagues '3 found that the tumour originated in an upper lobe in about 35% of published cases and in a lower lobe in 22%. In the remainder the site of origin was uncertain.
The isolated nodular form appears to be more common in the upper lobes and is frequently associated with a scar.250 The tumour may be minute or may be over 10 cm in diameter2 "' and is often circumscribed and roughly spherical, with a greyish white, mucoid cut surface.2 Others are less well defined and may be difficult to recognise as neoplastic.2 The adjacent pleura is frequently puckered, particularly in those cases associated with a scar. Cavitation is rare, but occurs sometimes in larger specimens. The cavity frequently contains mucus.
In the disseminated nodular form the individual tumours are similar in appearance to isolated The central part of the tumour frequently contains hyaline or collagenous scar tissue64250 and areas of necrosis. It also contains a variable amount of tissue with a frankly adenocarcinomatous structure,2 a feature which immediately raises the question of differential diagnosis between adenocarcinoma and alveolar carcinoma. It must be admitted that the distinction at light microscopy is somewhat arbitrary. In 1960 Liebow2 stated that no definition had succeeded in separating the two and that the question was unlikely to be resolved without further studies at an ultrastructural and histochemical level.
Histogenesis
The difficulty in distginguishing between alveolar carcinoma and other tumours has only partially been solved by the advent of the electron microscope. Doubts have been expressed about the existence of alveolar carcinoma as an entity separate from adenocarcinoma45"94-5 and even its status as a primary tumour of the lung has been questionednotably by Eck,96 who presented three cases of apparent alveolar cell carcinoma which were in fact secondary deposits from the rectum, pancreas, and bronchus. Other workers have described similar findings and emphasise that in many cases a pancreatic primary was responsible.9798 There is now abundant evidence that alveolar carcinoma does arise in the lung, although identical appearances can be produced by secondary tumours. Primary sites in pancreas, large bowel, gall bladder, ovary, thyroid, and breast have all been mentioned in this context and a careful search must always be made for unrecognised primary disease.635979
Because the histogenesis of alveolar carcinoma could not be ascertained by light microscopy, it was 170 named bronchioloalveolar carcinoma on the grounds that it was impossible to deny either a bronchiolar or an alveolar origin.2 To solve this problem, several ultrastructural studies were instituted. The results were wildly conflicting. Some workers were of the opinion that alveolar carcinoma arose from granular pneumocytes or type II cells, others thought that an origin from non-ciliated bronchiolar or Clara cells was more likely, and a third group favoured an origin from metaplastic mucus secreting cells. Dogmatic statements were made, often on the basis of a single case.
It is unthinkable that all these workers were wrong in the interpretation of their findings, and it is now clear that all were correct but had based their conclusions on series which were too small. In The differential diagnosis between adenocarcinoma and alveolar carcinoma is often arbitary and is in any event an artificial distinction in most cases. Nevertheless, the term remains a useful label which can be applied to peripheral lung tumours showing the characteristic spread along alveolar walls, with the proviso that the exact cell type may be uncertain on the basis of light microscopy. Such tumours carry a better prognosis than bronchogenic neoplasms. They present as small peripheral masses and often appear to grow slowly. The classic pneumonic and multinodular lesions are late manifestations. Bronchorrhoea is rare.
Further work is required on the possible viral aetiology of alveolar carcinoma, and the natural history of the various subtypes needs to be investigated.
